chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient verbalized to clinic nurse that one day after vaccine was given she had tingling in the right arm. Patient verbalized that the tingling has been " coming and going" since the vaccine was given. Patient spoke with provider and also reported redness and swelling to the site. Patient was instruct to come to the urgent care to be further evaluated. Patient agreed and presented to the clinic on 4/20/21. Patient was assessed and had labs draw there are no abnormalities at this time. Patient was educated on signs and symptoms to monitor for and when to seek medical attention.
After second shot didn't feel well; Arm was slightly sore; Tiredness but not was bad as after first shot; This spontaneous case was reported by an other health care professional and describes the occurrence of MALAISE (After second shot didn't feel well), MYALGIA (Arm was slightly sore) and FATIGUE (Tiredness but not was bad as after first shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included Autoimmune disorder since an unknown date.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 22-Apr-2021, the patient experienced MALAISE (After second shot didn't feel well), MYALGIA (Arm was slightly sore) and FATIGUE (Tiredness but not was bad as after first shot). On 24-Apr-2021, MALAISE (After second shot didn't feel well), MYALGIA (Arm was slightly sore) and FATIGUE (Tiredness but not was bad as after first shot) had resolved.            No treatment or concomitant products reported
Severe shivering, sweats, nausea, muscle aches and skin hurts to touch.
Received vaccine and then day later had swelling at site without redness. Used ice bag and swelling dissipated in 2 days.
Patient stated arm was swollen, red and had a hard area. Suggested icing it and to take BENADRYL.
Within 1/2 hr. of receiving the vaccine, the left side of my face went tingling/numb.  By evening it became very painful.  Pain running from behind my left ear over my left checks, including upper and lower jaw on left side.  By morning, I had blisters on top of my palate and part of my throat and in my sinus'.   Pain became increasingly worse over next few days.  Now on medication for it. I am hesitant to receive the second shot as I don't want to go through this again.  Please advise.
weakness, numbness "heaviness" at L upper arm. pain with ROM. no change in sx in last weeks. L grip mildy decreased compared to R grip. absent L triceps reflex.  due for EMG and NCS in next weeks.
arm pain; fatigue; chills; nausea; vomiting; This is a spontaneous report received from a contactable consumer reported for a  female patient received BNT162B2 (COVID-19 vaccine) on 10Apr2021 at single dose for covid-19 immunization. Medical history and concomitant drug were not reported. Patient experienced arm pain, fatigue, chills, nausea and vomiting on 11Apr2021 with outcome was unknown.  No follow-up attempts are needed. No further information is expected.
Low fever (100-101) within first 2 hours, held for 9 hours, then lowered to 99 for approx. 10 hours.  Back to 97.8 by 23 hours after injection.  (5 hours after injection, took 2 Ibuprofen, 200mg)  Moderate dizziness, fatigue and frontal headache for 15 hours, beginning 2 hours after injection.  Moderate asthma symptoms, 2.5 hours after injection: wheezing, cough, etc. (Used nebulizer and albuterol solution 1x., 6 hours after injection. Continued maintenance inhaler, Flovent, 2x a day, as usual)
This spontaneous case reported by a consumer, describes the occurrence of vaccination complication (first 2 doses gave side effects) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced vaccination complication (first 2 doses gave side effects). At the time of the report, vaccination complication (first 2 doses gave side effects) outcome: unknown. No concomitant medication or treatment information reported. This case linked to MOD-2021-350487 (patient link).
COVID19 FIRST-DOSE PFIZER VACCINE 345PP ADMINISTERED IN LEFT DELTOID, AND PATIENT STATED DISCOMFORT AFTER ADMINISTRATION. SHORTLY AFTERWARDS (WITHIN 15 SECONDS), PATIENT STATED FEELING DIZZY AND NOT WELL. SOON AFTERWARDS PATIENT LOST CONCIOUSNESS WHILE IN THE ADMINISTRATION CHAIR AND PROCEEDED TO SLOPE, REQUIRING THAT THE PATIENTS HEAD BE MANUALLY SUPPORTED. PATIENT DID NOT HIT THE FLOOR, BUT WITHIN 5 TO 10 SECONDS, THE PATIENT RETURNED TO CONCIOUSNESS. EMERGENCY SERVICES WAS THEN IMMEDIATELY REQUESTED TO BE CALLED. PATIENT LOOKED PALE AND WAS VISIBILY SWEATING AFTER FAINTING. PATIENT DENIES BREATHING ISSUES AT THE TIME, AND IT DID NOT APPEAR THAT THE PATIENT WAS BREAKING OUT IN HIVES, THEREFORE EPIPEN WAS NOT NECESSARY. AMBULATORY SERVICES ARRIVED WITHIN FIVE MINUTES AND TOOK OVER. PATIENT WAS ADVISED TO REMAIN IN THE FETAL POSITION UNTIL A STRETCHER COULD BE BROUGHT, WHEREBY EVENTUALLY PATIENT WAS ESCORTED OUT OF THE BUILDING IN A STRETCHER. THE PATIENT WAS CALLED A DAY LATER AND REPORTED FEELING FINE.
Information has been received from a certified medical assistant (C.M.A.) concerning a patient in his (or her) 70's with no pertinent medical history, drug reactions or allergies who on 01-JUL-2008 was vaccinated with a dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck). There was no concomitant medication. The reporter stated that she did not double check the vial and made the mistake. It was no product confusion. No adverse events reported. Follow-up information was received on 04-SEP-2008 from the C.M.A. concerning a 73 year old retired female who was administered a dose of VARICELLA (Merck) instead of ZOSTAVAX (Merck). The reporter confirmed that there was no adverse event. This is one of several reports from the same source. Additional information is not expected.
Rash about 1 1/2 inch area on arm of injection began 12 days post vaccine. On day 13,  a 2" by 3" second area of rash began; later same day a smaller, 1" area rash began. All three rashes on upper area of the arm the received the vaccine.  On day 14 (today), rash area #1 somewhat larger and puffier, 2nd area resolving, 3rd area a bit redder and puffier. All areas itch at times.
On February 1, induration, erythema, and itching were noted at the site of injection
"Moderna COVID-19 Vaccine EUA" -- patient hospitalized with covid19 after receiving one dose moderna vaccine.  66 y.o. female with hypertension and diabetes admitted with sharp abd pain, nausea, vomiting for several days. CT abd with cecal distention, findings concerning for cecal volvulus. Extended resp panel positive for SARS-CoV-2 (received 1st dose of COVID vaccine on 3/22). Went to OR for exploratory laparotomy, lysis of adhesion and right colectomy.   Patient was also found to be Covid-19 positive and needed supplemental oxygen in ED (3L NC at the time).  Imaging showing bilateral pulmonary infiltrates/effusions (and also cecal volvulus, as stated above, pt underwent exloratory laparotomy, lysis of adhesion, right colectomy with ilecolostomy).  Patient was recovering on medical floor when she clinically decompensated and needed increased oxygen and had a drop in blood pressure (confused, hypotensive, hypoxic).  Labs notable for BUN 37, creatinine 2.16, procalcitonin 17.62, Hgb 6.4 (10 on admission). ABG 7.35/ 28/ 73/ 16/ 94% on nasal cannula. 1 unit PRBC given. BP continued to be borderline and was placed on vasopressor briefly.  Empiric antibiotics vancomycin/cefepime/Flagyl, and patient was also started on remdesivir and dexamethasone.    Nadir O2 sat was 82% on 3/31/2021.  T=102.2 on 3/31/21.  Patients had multiple family members with Covid-19.  Treatments as stated above included Remdesivir and Dexamethasone.    Cultures negative - exact source of sepsis unclear: bacterial pneumonia vs. covid vs. intra-abdominal source   In ICU from 3/31 to 4/3.  Medical floor 4/3 to 4/7.  Patient was discharged home 4/7/21.
Patient received flu shot at 330pm. Felt nauseous on the way home. Vomited in the evening. Felt better right after. No further remedy needed.
Vaccine HPV received on 8-22-08 at pharmacy.  On 8-26-08 developed anxiety, dissociative type feelings, burning sensation in head, appetite loss, loose stools.  Symptoms gradually improved over 5 days.
Systemic: Exhaustion / Lethargy-Severe, Systemic: inability to walk normally (uneasy), sensitivity to light and sound, joint pain-Medium, Additional Details: pt has history of guillan barre (miller fisher syndrome) at 4 yo. experiencing similar symptoms
I had a migraine approximately 30 minutes after vaccine and took Excedrin (2 tabs) for migraine.
lt deltoid 6" x 4" reddened circle, hot & painful to touch;mild flu-like sxs, low-grade temp, fatigue & h/a
My arm and sholder are in so much pain, I can barely move my arm above my head.
COMPLAINTS OF LIGHTHEADEDNESS, SKIN PALE, MIDLY DIAPHORETIC, BP 100/60, PT STATED HE WORKED OUT PRIOR TO COMING FOR INJECTION AND DID NOT EAT. GIVEN ORANGE JUICE AND CRACKERS, LAID SUPINE WITH LEGS ELEVATED, AFTER 15 MIN SKIN DRY, NORMAL COLORATION, STATED HE FELT BETTER, BP 122/82. STABLE
Mother states received shots 2 days ago. Now child c/o pain to left arm. Right deltoid with redness and swelling 50 x 60mm, warm to touch.
woke up with cramping, shakes, vomiting, nausea, tongue swelling, took Benadryl woke up next am with no symptoms
Received breakthrough infection on Monday 12/6/21 while attending a gathering. Over 9 positive cases resulted from this gathering. Symptoms began Wednesday 12/8/21, initially as a sour stomach. The next day, I was feverish and had a headache. Runny nose, fogginess followed for the next 2-3 days. Night sweats during sleep. Overall, mild symptoms.
increased heart rate (120 resting); fever; chills; muscle fatigue; joint pain; migraines; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date as a single dose for COVID-19 immunisation and the patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, the patient experienced increased heart rate (120 resting), fever, chills, muscle, fatigue, joint pain and migraines. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The patient underwent lab tests and procedures which included nasal swab test for COVID-19 on an unknown date and the result was found to be negative. The clinical outcome of the events increased heart rate (120 resting), fever, chills, muscle, fatigue, joint pain and migraines were resolved with sequelae on an unknown date.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
1.5 hours after the vaccine, one eye vision was down to light perception only. The event lasted 15 minutes and resolved completely. ER eval and Ophtholology eval did not find a cause for the event.; This is a spontaneous report from a contactable physician. A 66-year-old male patient received bnt162b2 (reported as COVID 19, Covid vaccine, lot/batch number and expiry date were not provided), via an unspecified route of administration from 17Dec2020 12:30 at single dose for covid-19 immunisation.  Medical history included gout, abnormal glucose, hyperlipidemia, hypertension. Prior to vaccination, the patient was not diagnosed with COVID-19.  No Known allergies. Concomitant medications the patient received within 2 weeks of vaccination included atorvastatin, prednisone, lisinopril, allopurinol, famotidine (PEPCID). The patient experienced 1.5 hours after the vaccine, one eye vision was down to light perception only. The event lasted 15 minutes and resolved completely. ER eval and Ophtholology eval did not find a cause for the event. CT and labs done. Event onset date was on 17Dec2020 14:00.  The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. No treatment received for the adverse event. Case was non-serious. Facility where the most recent COVID-19 vaccine was administered at Hospital. The adverse event result in the following: Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. The outcome of event was recovered on 17Dec2020 14:15.   Information on the Batch/Lot number has been requested.
This spontaneous report as received from a nurse refers to multiple unspecified patients of unknown age and gender. No medical history and concurrent conditions were reported. On an unknown dates the patients were vaccinated with an improperly stored dose of M-M-R II (Lot number L034731, expiry date 09-SEP-2017, Lot number L035674, expiry date 17-SEP-2017) (dosing regimen and frequency unknown). No concomitant medications were reported. No adverse events were reported. The action taken and the outcome of the events was unknown. There was no product quality complaint reported. This case is linked to case number 1609USA014778 and 1609USA013289 via same reporter link. Additional information has been requested.
The reactions I have to the Flu vaccine are always the same but the adverse reaction time was become more rapid. This one was instantaneous. On Nov. 5, 2020, I went to Employee Heath to receive my free vaccine, this is the first time I had received this free vaccine. The moment that the fluid hit my muscle, I immediately experience vertigo with the entire room spinning, I went cold and clammy, and experience immediate nausea. I was told the color drained from my face with the gentleman coming out of the room next door because he saw my reaction and the monitor. I always have someone drive me to and from my vaccinations due to my previous adverse reactions. Before I even made it to the car, I went down in the parking lot because the lot started to spin and I became quite light headed. I live about 6 minutes from the hospital and before I even got home I was throwing up. I then experienced extreme nausea, vomiting, and diarrhea for the next three months. Following the vaccination, I missed meetings for work and even had to call off of a few shifts because I was unable to due my job.
I was diagnosed with COVID in July. I had extreme fatigue, loss of taste and smell. I had sinus infection. I also had a headache. The doctor saw COVID in the lungs but I never have a cough. I still have extreme fatigue and I have not got my taste back either.
Pt to ED 6/15 by EMS hypotensive with SOB and vomiting. 6/16 pt NSR/SB, VSS on room air. 6/17 pt A&ox1-2, extremities cold to the touch. COVID+ 6/17. 6/18 pt is a&o x1.vital signs are stable, continued IV Rocephin. 6/21 Patient AOx self. Vitals stable with no distress noted. No complaints of pain or discomfort. Remains on room air. Pt discharged 6/22, stable at time of discharge with no distress.
Experienced discomfort in (L) upper arm several hours after receiving flu vaccine in (L) deltoid on 11/1/16. Now on 11/17/16 states has had continued discomfort in (L) upper arm ever since 11/1/16. Pt ref to PCP.
Describes feeling 'weird".  dizzy, slightly SOB, felt large lump in back of throat- felt similar to when she has experienced an allergic reaction.  she did not report it to observers but later reported to me after arriving home and still not feeling 100% back to baseline.  she stayed in observation area for 40 minutes post vaccine.  Reports that she will consult her medical provider to decide if she should take the 2nd dose.
Patient awoke in the night with severe shaking, chills. Reports back and chest pain-began vomiting, then fainted and hit her head on toilet. Did not seek medical attention. Refuses second vaccine.
Patient began having confusion and worsening weakness into the evening.  This resulted in 2 falls at home.  Went to hospital.  Work up for infection showed no results.  Patient gradually improved over 3 days in hospital.
pt recv vax; warm, tender inflamed, rash extending from upper lt arm to elbow; dx as cellulitis; tx w/ diclox & heat;
Information has been received from a Dentist concerning a female who was vaccinated with Gardasil. Subsequently the patient experienced numbness in feet. Additional information has been requested.
pt recv vax 19APR96 & 8JUL96 lab eval revealed that pt failed to seroconvert;
Information has been received from a currently 74 years old female consumer referring to herself. The patient did not have any pertinent medical history or drug reactions/allergies. On an unknown date the patient was vaccinated with the first dose of PNEUMOVAX 23 (dose, lot# and expiration date were not reported) intramuscularly. The patient had been on many unspecified concomitant medications. On an unknown date, the patient developed breast cancer. On 09-NOV-2015 the patient was vaccinated with the second dose of PNEUMOVAX 23 intramuscularly (dose, lot# and expiration date were not reported) and experienced phlegm and hoarseness on the next day, 10-NOV-2015. No lab diagnostics studies had done. The patient did not seek medical attention or received any treatment for the events. The patient did not recover. The causality was not reported. Upon internal review, the event of breast cancer was considered to be medically significant. Additional information has been requested.
Pt was admitted to the hospital for reasons unrelated to COVID.  Screening testing on admission yielded positive results.  Pt was asymptomatic for COVID
sick; Based on information received on 24-Nov-2020, the report previously considered as non-valid became valid: as the patient had been reported clearly in the description.  Initial information received on 31-Oct-2020 regarding an unsolicited non-valid serious case from a consumer via social media.  This case involves a patient (unknown demography) who was sick (illness), after receiving INFLUENZA VACCINE.  Medical history, medical treatment, concomitant medication, vaccination and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a serious sickness (illness), (unknown latency) following the administration of INFLUENZA VACCINE. The patient was hospitalized for this event.  Details of laboratory data not reported.   It was not reported if the patient received a corrective treatment.  At the time of reporting, the outcome of event illness was not reported.  Information on the batch number was requested.  Follow up information received on 24-Nov-2020 regarding an unsolicited valid serious case from a consumer via social media.  Case became valid from non-valid.; Sender's Comments: Follow up information received on 24-Nov-2020, does not change the previous assessment of this case. This case involves a patient with unknown demography who had illness, after vaccination with INFLUENZA VACCINE (unknown manufacturer). The time to onset is unknown. Additional information regarding patient's medical history, condition at the time of vaccination, lab data excluding other etiologies would be needed for complete assessment of the case. Based upon the reported information, the role of the vaccine cannot be assessed.
Immediately following the vaccination I had muscle aches and sore injection site. Now, eleven days later my injection site is hard and very sore and hot to the touch.
Patient requested a "TDAP" shot. Shot administered. Patient stated she wanted a Tuberculin skin test not a Tetanus shot.
The patients was admitted with COVID after having the Pfizer COVID-19 vaccine; The patients was admitted with COVID after having the Pfizer COVID-19 vaccine; This is a spontaneous report from a contactable other HCP (nurse) from a Pfizer sponsored program. A 79-years-old patient of an unspecified gender received unknown dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number, NDC number and expiry date were not reported) via an unspecified route of administration on an unspecified date as a single dose for covid-19 immunization. The patient's medical history, investigation assessment and concomitant medications were not reported. The report was not related to a study or programme. The nurse reported that the patient was admitted with covid after having Pfizer covid-19 vaccine. Antibodies were not tested. The outcome of the event was unknown.  The lot number for the vaccine BNT162B2 was not provided and will be requested during follow up.; Sender's Comments: Based on the information in the case report and a plausible temporal relationship,  a possible causal relationship between the events of  DI , Covid 19 and suspect drug BNT162B2 cannot be excluded,Linked Report(s) : US-PFIZER INC-202100957229 same reporter, different patient, same drug, similar events
24 hours after his booster he started to feel bad, loss of appetite, fatigued, sour stomach, low fever of 99.5  F.   32 hours after dose he started to show signs of conjunctivitis in his right eye, tender lymph  in the armpit region with continued symptoms previously stated along with a higher fever around 100 F.  36 hours post booster continued fever along with other symptoms, restless sleeping, right eye producing mucus and very red and itchy.  48 hours post injection, awoke with difficulty breathing and a very scratchy throat, still a fever 101-102.3 F. The right eye has started to resolve but other symptoms have stayed the same along with extreme fatigue, shaking, chills, hallucinations upon waking from a nap. The difficulty breathing resolved itself, but Unable to walk because it makes him feel sick.  Throughout all of this he has been given IBUPROFEN, which brings the fever down to 99-100.  Pushing fluids and rest.